Skip to main content

Table 1 Demographic and clinical characteristics of CML patients sensitive and insensitive to IM treatment

From: Global identification of circular RNAs in imatinib (IM) resistance of chronic myeloid leukemia (CML) by modulating signaling pathways of circ_0080145/miR-203/ABL1 and circ 0051886/miR-637/ABL1

Characteristics

Serum circHIPK3

X2 test P value

Responder (N = 66)

Non-responder (N = 42)

Age

 < 60

42

31

0.531

 ≥ 60

24

11

 

Gender

 Male

36

25

0.339

 Female

30

17

 

Sokal RR

 

 Low

25

17

0.744

 Intermediate

23

15

 

 High

18

10

 

BCR/ABL

 

 Mutated

0

0

0.209

 Unmutated

66

42

 
Back to article page

Molecular Medicine

ISSN: 1528-3658